Professional Opportunity Director / Associate Director of Scientific Affairs and Partnerships Download Job Description Here The Opportunity: CurePSP seeks a Director or Associate Director of Scientific Affairs and Partnerships. This role offers the opportunity to advance key strategic initiatives and partnerships as a senior member of a leading neuroscience nonprofit. This position reports to CurePSP’s Executive Director …
A scientist with broad experience in life sciences will lead the organization’s research, programs, and fundraising initiatives. NEW YORK, NY (August 9, 2021) /PRNewswire/ – CurePSP, the foundation for prime of life neurodegeneration, has named Kristophe Diaz, PhD, as its new executive director and chief scientific officer. In this planned succession, he succeeds David Kemp as …
Every year we are continuously growing our number of volunteers who are helping spread awareness and hosting fundraisers to support our vital programs and services. CurePSP is incredibly thankful for all of the effort and hard work that our community demonstrates. We are always looking for new ways to display everything you all do for …
CurePSP is proud to present the new forum to our community of people affected by PSP, CBD, and related prime of life brain diseases. The previous forum was a well used and much loved space for many people to reach out and connect with others going through the same journey, sharing ideas, thoughts, and words …
This press release was published at 10am Wednesday, November 15, in PR Newswire. NEW YORK, Nov. 15, 2017 /PRNewswire/ — CurePSP, the leading nonprofit advocacy organization for prime of life neurodegenerative diseases, today announced the launch of a global initiative tied to Giving Tuesday, #PiesforPSP, to support individuals and families who have been affected by …
New Diagnosis Criteria Established for PSP. In a groundbreaking development, an international collaboration of neurologists and movement disorder specialists have convened to agree on a a revision of the previous PSP diagnostic criteria. CurePSP has worked closely with many of the collaborators involved, and is very excited about this new development. “The new diagnostic criteria are …
In this article, Trish Caruana, Vice President – Patient and Carepartner Advocacy explains what advocacy is, and the common hurdles people face when considering advocacy. Care, consciousness and cure are central to the mission of CurePSP, but how we advocate for people with PSP and other prime of life diseases is also important. The lack of …
AbbVie Initiates Phase 2 Clinical Trial Programs for ABBV-8E12, an Investigational Anti-Tau Antibody, in Early Alzheimer’s Disease and Progressive Supranuclear Palsy Jan 25, 2017 Courtesy of AbbVie, January 2017 – Initiation of Phase 2 clinical trial programs in early Alzheimer’s disease and progressive supranuclear palsy (PSP) is part of ongoing commitment to investigate ABBV-8E12 …
Friedman family has committed up to $600,000 New York, NY (June 29, 2016) — CurePSP, the leading nonprofit advocacy organization focused on prime of life neurodegenerative diseases, today announced a matching grant challenge of up to $600,000 from the Friedman family to accelerate genetics research. An initial contribution of $250,000 toward this goal has been …
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.